|
Terry Herring 42 is Chief Operating Officer inVentiv Health and President and CEO of inVentiv Commercial overseeing the Ventiv Pharma Teams Ventiv Pharma Services and Ventiv Pharma Analytics divisions of this business segment. He has more than 19 years' experience in the pharmaceutical sales industry and previously held the positions of National Business Director Vice President and General Manager U. S. Sales and President and COO Ventiv Pharma Services prior to his appointment to President and COO of the commercial business in 2005. Under Mr. Herring's leadership inVentiv Commercial has delivered strong revenue growth and a five-fold increase in income. In October 2005 Mr. Herring was appointed to the Board of Directors of inVentiv Health Inc. and was named Chief Executive Officer of inVentiv Commercial in February 2006.
Before joining inVentiv Mr. Herring was the Senior National Sales Director at Noven Pharmaceuticals where he focused on transdermal delivery and women's health marketing. He began his career at Ciba-Geigy Pharmaceuticals and Solvay Pharmaceuticals where he held various sales management training development marketing and operations positions.
Mr. Herring graduated magna cum laude from the Citadel Military College of South Carolina where he earned a B.S. in Biology. He also attended Fairleigh Dickinson and Pacific Western University where he earned his M.B.A. In addition Mr. Herring has received graduate certificates in business and international marketing from Mercer University School of Engineering and Duke University/London Business School. | 